Megan Zoschg Canniere, Pharm D

Megan Zoschg Canniere is the Head of Regulatory Affairs & Patient Safety for Spark Therapeutics, Inc. where she has worked since 2020. In her current role she leads the cross-regulatory, medical writing, and safety & pharmacovigilance teams to develop and implement innovative regulatory strategies and manage the safety for our AAV-based gene therapies. Previously, over 16 years at Roche/Genentech, Megan held roles of increasing responsibility culminating in several years as the Regulatory Franchise Head for Neurodegeneration and Rare Diseases – a role which brought out her passion for rare diseases, and for the potential of gene therapy. Before joining Roche, Megan started her regulatory career at Johnson & Johnson, following completion of a Doctor of Pharmacy degree at the University of Pittsburgh.